Pass the patch. The US is in the middle of an estrogen patch shortage, with menopausal women struggling to get ahold of ...

New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transdermal Skin Patches Global Market Report 2023" - https://www ...

As more and more research hints at the potential therapeutic uses of psychedelics, finding new ways to deliver the powerful drugs has taken on new interest. For example, the active component of ...

Eight years ago, I wrote about a startup trying to deliver cancer drugs through the skin. That company is long gone, but is the market for so-called transdermal (across the skin) drug delivery a good ...

Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today ...

An innovative delivery method for human immunodeficiency virus medications has been developed through use of a transdermal patch, the first of its kind to treat HIV. An innovative delivery method for ...

March 30, 2011 (Toronto, Ontario) — Caregivers using a transdermal patch to administer cholinesterase inhibitor (ChEI)–based therapy in individuals with Alzheimer's disease (AD) report greater overall ...

An enhanced instrument for testing drug release from transdermal patches has been developed by Medherant. Medherant, a bioadhesives company formed as a spin-out from the University of Warwick (UK) in ...

The US Food and Drug Administration (FDA) has approved donepezil transdermal system (Adlarity) for patients with mild, moderate, or severe Alzheimer's disease (AD), the manufacturer has announced.

It was a severe vitamin D3 deficiency that introduced Yashovardhan Kanodia, 35, co-founder of East Star Financial Advisors in Kolkata to vitamin patches. Racked by aches and pains in his body, he ...

Minimize reactions to transdermal patches Applying triamcinolone prior to a transdermal patch helps prevent contact dermatitis. If a patient has a mild reaction to the adhesive on a transdermal patch, ...

It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...